Not provided
Not provided
Not provided
Not provided
Not provided
low enrollment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| open-label placebo | Experimental | open-label placebo |
|
| treatment as usual | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Placebos | Drug | placebo pills |
|
| Measure | Description | Time Frame |
|---|---|---|
| dyspepsia severity on a VAS from 0-100 | How severe have your dyspepsia symptoms been over the past 7 days (on a VAS from 0-100)? | 3 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004415 | Dyspepsia |
| ID | Term |
|---|---|
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Arm 1: open-label placebo Arm 2: treatment as usual control
Not provided
Not provided
Not provided
Not provided